OPKO HEALTH, INC. (OPK)

↓ Download CSV

CIK 0000944809 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, OPKO HEALTH, INC. reported revenue of $606.88M, down 14.9% from the prior year. The company ran a net loss, with a net margin of -37.2% and a gross margin of 33.9%. It held $1.93B in total assets against $663.99M in total liabilities.

Key ratios (FY2025)

33.9%
Gross margin
-19.3%
Operating margin
-37.2%
Net margin
-17.8%
Return on equity
-14.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$606.88M$713.14M$863.50M$1.00B$1.77B$1.44B$901.93M$990.27M$966.01M$1.12B
Cost of Revenue$400.94M$494.63M$545.37M$715.98M$564.10M
Gross Profit$205.94M$218.51M$318.13M$288.22M
Operating Income-$117.41M-$152.06M-$157.02M-$226.25M$18.75M$57.71M-$274.05M-$171.20M-$276.44M-$96.55M
Net Income-$225.68M-$53.22M-$188.86M-$328.40M-$30.14M$30.59M-$314.93M-$153.04M-$305.25M-$48.36M
EPS (Diluted)$-0.30$-0.08$-0.25$-0.46$-0.05$0.05$-0.53$-0.27$-0.55$-0.09
Total Assets$1.93B$2.20B$2.01B$2.17B$2.40B$2.47B$2.31B$2.45B$2.59B$2.77B
Total Liabilities$663.99M$834.76M$622.48M$605.61M$714.59M$801.51M$694.51M$659.78M$746.33M$674.81M
Shareholders' Equity$1.27B$1.37B$1.39B$1.56B$1.69B$1.67B$1.61B$1.79B$1.84B$2.05B
Cash & Equivalents$364.41M$426.58M$95.88M$153.19M$134.71M$72.21M$85.45M$96.47M$91.50M$168.73M
Operating Cash Flow-$178.54M-$183.49M-$28.20M-$95.19M$38.34M$39.48M-$172.52M-$109.14M-$92.08M$32.05M
Capital Expenditures$12.28M$25.01M$16.27M$24.58M$32.16M$33.68M$12.74M$27.86M$46.52M$18.55M
Shares Outstanding751.13M694.02M751.77M719.06M648.08M640.66M595.45M563.14M559.16M555.61M